The next generation of therapeutics for chronic kidney disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd.2016.67.pdf
Reference296 articles.
1. Collins, A. J., Foley, R. N., Gilbertson, D. T. & Chen, S. C. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int. Suppl. 5, 2–7 (2015).
2. Kovesdy, C. P. et al. Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J. Am. College Cardiol. 61, 1626–1633 (2013).
3. Foley, R. N. & Collins, A. J. The USRDS: what you need to know about what it can and can't tell us about ESRD. Clin. J. Am. Soc. Nephrol. 8, 845–851 (2013).
4. Weiner, D. E. et al. Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial. Am. J. Transplant. 12, 2437–2445 (2012).
5. Herzog, C. A. et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 80, 572–586 (2011).
Cited by 195 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Fibroblast growth factor 21 alleviates unilateral ureteral obstruction-induced renal fibrosis by inhibiting Wnt/β-catenin signaling pathway;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-02
2. Synthesis and biological evaluation of 2′-hydroxychalcone derivatives as AMPK activators;Bioorganic Chemistry;2024-02
3. Modeled microgravity unravels the roles of mechanical forces in renal progenitor cell physiology;Stem Cell Research & Therapy;2024-01-17
4. The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis;Frontiers in Pharmacology;2024-01-16
5. Guben Xiezhuo Decoction inhibits M1 polarization through the Raf1/p-Elk1 signaling axis to attenuate renal interstitial fibrosis;Journal of Ethnopharmacology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3